https://lsif.dk/ weekly 1.0 https://lsif.dk/portfolio weekly 0.9 https://lsif.dk/news daily 0.9 https://lsif.dk/cookie-policy yearly 0.3 https://lsif.dk/portfolio/monivent monthly 0.7 https://lsif.dk/portfolio/fluoguide monthly 0.7 https://lsif.dk/portfolio/acarix monthly 0.7 https://lsif.dk/portfolio/scibase monthly 0.7 https://lsif.dk/portfolio/acucort monthly 0.7 https://lsif.dk/portfolio/bibbinstruments monthly 0.7 https://lsif.dk/portfolio/sprint-bioscience monthly 0.7 https://lsif.dk/portfolio/prostatype-genomics monthly 0.7 https://lsif.dk/portfolio/senzagen monthly 0.7 https://lsif.dk/portfolio/newbury-pharmaceuticals monthly 0.7 https://lsif.dk/portfolio/nosa-plugs monthly 0.7 https://lsif.dk/portfolio/acousort monthly 0.7 https://lsif.dk/portfolio/lipidor monthly 0.7 https://lsif.dk/portfolio/pmd-solutions monthly 0.7 https://lsif.dk/portfolio/xspray-pharma monthly 0.7 https://lsif.dk/news/biostock-medtech-summit-2026 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-largest-guarantor-bibbinstruments-rights-issue 2026-03-14 monthly 0.6 https://lsif.dk/news/bibbinstruments-releases-good-news 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-increases-acucort 2026-03-14 monthly 0.6 https://lsif.dk/news/fluoguide-fda-fast-track-mar24 2026-03-29 monthly 0.6 https://lsif.dk/news/acousort-secures-additional-runway 2026-03-29 monthly 0.6 https://lsif.dk/news/fluoguide-news-end-2025 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-further-support-scibase 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-invests-in-scibase 2026-03-14 monthly 0.6 https://lsif.dk/news/bibbinstruments-loi-taewoong 2026-03-14 monthly 0.6 https://lsif.dk/news/pmd-bump-on-road 2026-03-14 monthly 0.6 https://lsif.dk/news/-lsif-to-increase-subscription-in-current-rights-issue-in-bi 2026-04-12 monthly 0.6 https://lsif.dk/news/-acucort-ab-with-good-news-regarding-fda-in-the-us 2026-04-13 monthly 0.6 https://lsif.dk/news/more-good-news-from-scibase-feb26 2026-03-14 monthly 0.6 https://lsif.dk/news/sprint-bioscience-up-116-today 2026-03-14 monthly 0.6 https://lsif.dk/news/news-from-bibbinstruments-jun 2026-03-14 monthly 0.6 https://lsif.dk/news/acucort-financing-success 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-leads-acucort-financing 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-major-investor-monivent 2026-05-10 monthly 0.6 https://lsif.dk/news/-acarix-solution-to-rule-out-cad-featured-on-fox-news 2026-04-12 monthly 0.6 https://lsif.dk/news/senzagen-record-gard-sales 2026-03-14 monthly 0.6 https://lsif.dk/news/multiple-good-news-from-scibase 2026-03-14 monthly 0.6 https://lsif.dk/news/jan-poulsen-chairman-acarix 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-invests-in-newbury-pharmaceuticals 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-invest-bibbinstruments 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-invests-xspray-pharma 2026-03-29 monthly 0.6 https://lsif.dk/news/positive-acarix-announcement-today 2026-03-14 monthly 0.6 https://lsif.dk/news/acucort-signs-distribution-agreement 2026-03-14 monthly 0.6 https://lsif.dk/news/scibase-secures-96-subscription-rights-issue 2026-03-14 monthly 0.6 https://lsif.dk/news/fluoguide-submits-ind-fg001 2026-03-14 monthly 0.6 https://lsif.dk/news/acarix-raises-33m-sek-directed-issue 2026-03-14 monthly 0.6 https://lsif.dk/news/fluoguide-enrolls-first-patient-phase-ii 2026-03-14 monthly 0.6 https://lsif.dk/news/lipidor-advances-phase-iii 2026-03-14 monthly 0.6 https://lsif.dk/news/participating-biostock-life-science-summit-2025 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-increases-investment-scibase 2026-03-14 monthly 0.6 https://lsif.dk/news/again-good-news-from-acarix 2026-03-14 monthly 0.6 https://lsif.dk/news/very-exciting-news-from-acarix 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-supports-subscription-acucort 2026-03-14 monthly 0.6 https://lsif.dk/news/very-good-news-from-acucort 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-invests-nosa-plugs 2026-03-14 monthly 0.6 https://lsif.dk/news/good-news-from-acarix-jun 2026-03-14 monthly 0.6 https://lsif.dk/news/prostatype-genomics-full-subscription 2026-03-14 monthly 0.6 https://lsif.dk/news/jan-poulsen-board-acucort 2026-03-14 monthly 0.6 https://lsif.dk/news/acucort-strengthens-management 2026-03-14 monthly 0.6 https://lsif.dk/news/negative-news-lipidor 2026-03-14 monthly 0.6 https://lsif.dk/news/acarix-innovation-award 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-invests-acousort 2026-05-11 monthly 0.6 https://lsif.dk/news/lsif-invests-sprint-bioscience 2026-05-11 monthly 0.6 https://lsif.dk/news/lipidor-home-stretch 2026-05-11 monthly 0.6 https://lsif.dk/news/senzagen-q3-report 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-lead-guarantor-bibbinstruments 2026-03-14 monthly 0.6 https://lsif.dk/news/acucort-nomination-committee 2026-03-14 monthly 0.6 https://lsif.dk/news/prostatype-press-releases 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-increases-acarix-investment 2026-03-14 monthly 0.6 https://lsif.dk/news/lipidor-phase-iii-progress 2026-03-14 monthly 0.6 https://lsif.dk/news/fluoguide-next-step 2026-03-14 monthly 0.6 https://lsif.dk/news/prostatype-high-subscription 2026-03-14 monthly 0.6 https://lsif.dk/news/prostatype-italy-order 2026-03-14 monthly 0.6 https://lsif.dk/news/pmd-q3-results 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-heads-lipidor-nomination 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-underwriter-scibase 2026-03-14 monthly 0.6 https://lsif.dk/news/acarix-nomination-committee 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-invests-pmd 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-major-shareholder-prostatype 2026-03-14 monthly 0.6 https://lsif.dk/news/acarix-ceo-buys-shares 2026-03-14 monthly 0.6 https://lsif.dk/news/acarix-secures-to3 2026-03-14 monthly 0.6 https://lsif.dk/news/lipidor-on-track 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-further-invest-acarix 2026-03-14 monthly 0.6 https://lsif.dk/news/acarix-new-segment 2026-03-14 monthly 0.6 https://lsif.dk/news/prostatype-spain-progress 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-lead-guarantor-prostatype 2026-03-14 monthly 0.6 https://lsif.dk/news/fluoguide-60m-raise 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-invests-senzagen 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-lead-guarantor-pmd 2026-03-14 monthly 0.6 https://lsif.dk/news/fluoguide-laser-system 2026-03-14 monthly 0.6 https://lsif.dk/news/acarix-board-news 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-lipidor-commitment 2026-03-14 monthly 0.6 https://lsif.dk/news/acarix-important-development 2026-03-14 monthly 0.6 https://lsif.dk/news/lsif-acucort-exciting-news 2026-03-14 monthly 0.6 https://lsif.dk/news/fluoguide-raises-sek-104m-private-placement 2026-03-14 monthly 0.6 https://lsif.dk/news/-lsif-becomes-the-largest-shareholder-in-bibbinstruments 2026-04-22 monthly 0.6 https://lsif.dk/news/sprint-disappointing-start 2026-05-11 monthly 0.6 https://lsif.dk/news/-encouraging-operational-milestones-from-scibase 2026-07-20 monthly 0.6